Allergan has reported revenues from continuing operations up by 48 percent to $3.8 billion for the quarter ended March 31, 2016, as compared to the first quarter of 2015. The strong performance was primarily driven by global sales of branded products and sales of top global products within the U.S. ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.